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Abstract: Clinical differential diagnosis of arteriolosclerotic ulcers of Martorell is challenging due to the
lack of clearly affirmative instrument-based diagnostic criteria. The aim of this study was to develop
vascular histomorphological diagnostic criteria differentiating Martorell ulcers from other types of leg
ulcers. The histomorphology of patients diagnosed with arteriolosclerotic ulcers of Martorell (n = 67) was
compared with that of patients with venous leg ulcers, necrotizing leukocytoclastic vasculitis, pyoderma
gangrenosum, and non-ulcerative controls (n = 15 each). In a multivariable logistic regression model,
the rates of arteriolar calcification (odds ratio (OR) 42.71, 95% confidence interval (CI) 7.43–443.96, p <
0.001) and subendothelial hyalinosis (OR 29.28, 95% CI 4.88–278.21, p <0.001) were significantly higher
in arteriolosclerotic ulcers of Martorell. Arteriolar cellularity was significantly lower in Martorell ulcers
than in controls (OR 0.003, 95 CI < 0.001–0.97, p = 0.05). However, the wall-to-lumen ratio was similar
in all ulcers (OR 0.975, 95% CI 0.598–2.04, p =0.929). Based on the Youden index, a wall cellularity of <
0.24 cells/100 ฀m2 was determined as the optimum cut-off point (sensitivity 0.955, specificity 0.944). Thus,
arteriolar calcification, subendothelial hyalinosis, and arteriolar cellularity revealed high discriminatory
power for arteriolosclerotic ulcers of Martorell.
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SIGNIFICANCE
The arteriolosclerotic ulcer of Martorell is characterized by 
necrotic leg ulcers and is associated with long-standing 
arterial hypertension. Differential diagnosis, however, is 
challenging due to a lack of clearly affirmative instrument-
based diagnostic criteria. This study provides quantitative 
histomorphological information on arteriolar wall changes 
in patients with arteriolosclerotic ulcer of Martorell in com-
parison with ulcerative and/or non-ulcerative controls. This 
information may facilitate the histological diagnosis, diffe-
rentiating Martorell ulcers from other types of leg ulcers, 
and may also contribute to a better understanding of the 
aetiopathogenesis of the disease.
Clinical differential diagnosis of arteriolosclerotic ul-
cers of Martorell is challenging due to the lack of clearly 
affirmative instrument-based diagnostic criteria. 
The aim of this study was to develop vascular histo-
morpho logical diagnostic criteria differentiating 
Martorell ulcers from other types of leg ulcers. The 
histo morphology of patients diagnosed with arteriolo-
sclerotic ulcers of Martorell (n = 67) was compared 
with that of patients with venous leg ulcers, necro-
tizing leukocytoclastic vasculitis, pyoderma gangre-
nosum, and non-ulcerative controls (n = 15 each). In 
a multivariable logistic regression model, the rates 
of arteriolar calcification (odds ratio (OR) 42.71, 
95% confidence interval (CI) 7.43–443.96, p < 0.001) 
and subendothelial hyalinosis (OR 29.28, 95% CI 
4.88–278.21, p <0.001) were significantly higher in 
arteriolosclerotic ulcers of Martorell. Arteriolar cellula-
rity was significantly lower in Martorell ulcers than in 
controls (OR 0.003, 95 CI < 0.001–0.97, p = 0.05). Ho-
wever, the wall-to-lumen ratio was similar in all ulcers 
(OR 0.975, 95% CI 0.598–2.04, p =0.929). Based on 
the Youden index, a wall cellularity of < 0.24 cells/100 
μm2 was determined as the optimum cut-off point 
(sensitivity 0.955, specificity 0.944). Thus, arteriolar 
calcification, subendothelial hyalinosis, and arteriolar 
cellularity revealed high discriminatory power for ar-
teriolosclerotic ulcers of Martorell. 
Key words: arteriolosclerosis; Martorell; leg ulcer; histomorpho-
l ogy; hyalinosis.
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The differential diagnosis of leg ulcers covers a wide range of diagnoses, often posing a difficult diag-
nostic challenge. Approximately 75% of all ulcers occur 
due to vascular aetiologies (1). While most leg ulcers 
are caused by chronic venous insufficiency (2), arterial 
disease represents the second leading cause (3). Besides 
peripheral arterial occlusive disease, stenotic diseases of 
the cutaneous arterioles are also significant. Originally 
described by Fernando Martorell in 1945 (4, 5), the ar-
teriolosclerotic ulcer of Martorell (ASUM) is defined 
by several characteristics. These include location of the 
ulcer on the lower leg, absence of relevant macrovascular 
diseases, disproportionate pain, and longstanding arterial 
hypertension (4, 5). It is characterized by skin infarctions, 
presenting with deep necrotic ulcers and purple-reddish 
edges (6). Although the exact prevalence of ASUM 
remains to be elucidated, recent reports estimate that it 
accounts for up to 5% of all leg ulcers (7). Treatment 
with sharp necrosectomy, followed by vacuum-assisted 
negative pressure and split-thickness skin grafting, has 
achieved the most successful results, leading to remis-
sion in up to 90% of patients (7). However, the clinical 
differential diagnosis is challenging, given the lack of 
clearly affirmative instrument-based diagnostic criteria. 
Nevertheless, the differential diagnosis of ASUM har-
bours the risk of underdiagnosis or misdiagnosis. This 
is particularly disconcerting considering the reports of 
frequent misdiagnosis with necrotizing leukocytoclastic 
vasculitis or pyoderma gangrenosum (PG), potentially 
resulting in fatal complications due to immunosuppres-
sive treatment (1, 7–10). Previously published diagnostic 
criteria (4, 5, 11), such as arterial hypertension or tissue 
necrosis, are not specific to ASUM. Thus, the criteria 
can only be used to stratify risk populations. In addition, 
considering that the patient population of ASUM consists 
primarily of multimorbid elderly patients, mixed ulcer 
aetiologies are frequent (7, 12–14). Uncovering a poten-
tial arteriolosclerotic component in these cases, based 
simply on clinical criteria, seems impossible. Therefore, 
histological assessment of peri-ulcerative skin biopsies 
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has gained increasing interest over the years. Although 
several authors have advocated for a bioptic assessment in 
suspected cases (7, 13, 15), others question its value (16, 
17). Since the first report on histopathology in ASUM by 
Faber & Hines (18), several different “typical” histologi-
cal findings in patients with ASUM have been reported. 
Accordingly, histological investigation of peri-ulcerative 
biopsy specimens evolved into an ancillary element of its 
diagnosis (6, 13, 19) (Table SI1). However, the specificity 
of these findings has been questioned, and remains a 
subject of ongoing controversial scientific discussions. 
Currently, there are no generally accepted and validated 
histological criteria for ASUM (6, 8, 16, 20, 21). In ad-
dition, no comparative study of the histomorphology of 
ASUM vs other types of leg ulcers has been conducted.
Therefore, this study aimed at a systematic multimodal 
microstructural analysis of deep skin biopsies of a large 
series of patients diagnosed with ASUM in 3 independent 
European academic dermatological wound centres. To 
determine the specificity of the results, the histopatho-
logical and microstructural vascular findings of patients 
diagnosed with ASUM were systematically compared 
with patients with venous leg ulcers, necrotizing leuko-
cytoclastic vasculitis, and pyoderma gangrenosum, repre-
senting the most important clinical differential diagnoses 
of ASUM. In addition, findings were compared with 
samples from non-ulcerative skin of non-hypertensive 
and hypertensive controls. These results may serve as 
a basis for the development of histological “minimal 
diagnostic criteria”, compatible with the diagnosis of 
ASUM in suspected cases.
MATERIALS AND METHODS
This study was conducted in compliance with Good Clinical 
Practice and the Declaration of Helsinki (22) and in accordance 
with the Austrian and Swiss laws. The study protocols and patient 
enrolment were formally approved by the local ethics committees 
at the Medical University of Vienna (number 2017-1171), the 
Canton of Zurich (number 2017-00290), and the Canton of Bern 
(number 2017-01216). 
Case selection
This study included patients diagnosed with ASUM between 1998 
and 2019 at the University Hospital of Vienna in Austria, the 
University Hospital of Zurich in Switzerland, and the University 
Hospital of Bern in Switzerland. The “ASUM” diagnosis was 
based on clinical and histological presentations (for details, see 
Appendix S11). The ASUM study group was compared with the 
following control groups: venous leg ulcers (Venous), necrotizing 
leukocytoclastic vasculitis (Vasculitis), pyoderma gangrenosum 
(PG), non-ulcerative skin of non-hypertensive controls (Control 
N), and non-ulcerative skin of hypertensive controls (Control H). 
Skin biopsies from ulcers were performed for diagnostic reasons, 
according to previous recommendations on biopsies in patients 
with ASUM (1, 7, 13). Biopsies extended from the edge of the 
ulceration, including: (i) the healthy adjacent skin, (ii) the wound 
margin, and (iii) the ulcer ground itself. Biopsies were performed 
in an elliptical shape with a length:width ratio of > 3:1 and exten-
ded into the deep subcutaneous tissue (in most cases down to the 
fascia of the muscle). All non-ulcerative healthy control samples 
were recruited from patients receiving re-excisions after previous 
tumour excisions on the lower leg (without signs of the initially 
described neoplastic tissue). 
Histological analysis
All histological specimens were initially stained with haematoxylin 
and eosin (H&E). Based on previous publications on the vascular 
histological criteria of ASUM (see Table SI1), the following criteria 
were selected for in-depth assessment of arterioles at the dermal-
subcutaneous junction: (i) quantification of the wall-to-lumen 
ratio according to a method adapted from a previously published 
protocol (23); (ii) quantification of subendothelial “hyalinosis”, 
defined as the accumulation of an amorphous, eosinophilic sub-
stance, supposedly consisting of plasma proteins, collagen, lipids 
and basement membrane material, in the media of arteriolar ves-
sels, including the calculation of a cellularity index (nuclei per 
100 μm2 vessel wall surface); (iii) evaluation of the presence of 
arteriolar calcification; and (iv) scoring of periarteriolitis. All non-
artificial intelligence histological assessments were independently 
performed by 2 operators (for details, see Appendix S11).
Convolutional neural network analysis
To evaluate the vascular histomorphological distinguishability 
between ASUM and the control groups, an operator-independent 
analysis was performed using convolutional neural networks 
(CNN). The learned task of the CNN was to predict the diagnosis 
of a case based on a series of manually acquired histological 
image crops, showing vessels and their immediate surroundings 
at the dermal-subcutis junction. Target classes were binarized to 
“ASUM” and “Not ASUM”. Twenty percent of the cases were split 
for final test evaluations. To obtain predictions for a case rather 
than single images, the predicted probability of “ASUM” was 
averaged over all images of a single case. The resulting value was 
measured for cases included in the validation set, and an optimal 
cut-off value with the highest sensitivity and specificity was set. 
Given that ASUM is a rare type of leg ulcer, more emphasis was 
placed on sensitivity; and it was provided twice the weight on 
this measurement. The test set included 523 images with a mean 
of 8 images (standard deviation ± 6.5) per lesion (for details, see 
Appendix S11).
Discriminatory power and biostatistical analysis
For statistical comparison, Fisher’s exact tests were performed 
for binary variables and Wilcoxon–Mann–Whitney tests for con-
tinuous variables. p ≤ 0.05 were considered statically significant. 
p ≤ 0.01 were considered highly significant. The significance levels 
were adjusted using a Bonferroni post-hoc correction (24), if app-
licable. Continuous variables are depicted as medians (interquartile 
ranges; IQR), if not indicated otherwise. A logistic regression 
model was defined, using the diagnosis of ASUM vs controls as the 
target variable and wall-to-lumen ratio, calcification, hyalinosis, 
and cellularity index as explanatory variables. A second model with 
only calcification and cellularity index as explanatory variables 
was defined. Receiver operating characteristic (ROC) curves were 
generated to test the goodness of both models. Optimal cut-off 
values for cellularity dependent on the presence of calcification 
for ASUM vs controls were obtained by calculating the Youden 
index in the model that included only calcification and cellularity as 
the explanatory variables. All statistical analyses were performed 
using IBM SPSS Statistics 24 (IBM Inc., Armonk, NY, USA) or 
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RESULTS
Case selection and patient characteristics
A total of 67 patients with ASUM passed the eligibi-
lity criteria. In addition, 15 patients per control group 
(Venous, Vasculitis, PG, Control N, Control H) were 
selected for the study. Altogether, 156 samples from 
142 patients were analysed, resulting in an assessment 
of 921 arterioles. 
All 67 (100%) patients with ASUM had been diagnosed 
with arterial hypertension, 33 (49%) had diabetes melli-
tus type II (DM II), 12 (18%) had renal insufficiency, 12 
(18%) had peripheral arterial occlusive disease (PAOD 
stage I), and 16 (24%) had chronic venous disease (CVD, 
Clinical-Etiological-Anatomical-Pathophysiological 
stage < C4). All patient characteristics are summarized 
in Table SII1.
Arteriolar hyalinosis
Arteriolar subendothelial hyalinosis is characterized 
by the deposition of glassy, amorphous fibrosclerotic 
material in arteriolar walls. Based on conventional 
H&E histology, 62 (93%) patients with ASUM showed 
hyalinized arteriolar vessels. This was significantly more 
than that in all control groups (all p < 0.001), in which 
hyalinization could only be detected sporadically. The 
median share of hyalinized vessels in ASUM samples 
was 50% (28.57–70.00), which was also significantly 
higher than that in all other groups (0%, 0.00–0.00, 
p < 0.001) (Fig. 1a). 
Cellularity index
To quantify the fibrosclerotic subendothelial changes 
(“hyalinosis”) resulting in acellular concentric matrix 
Fig. 1. Assessment of hyalinosis 
and arteriolar wall-to-lumen ratio. 
(a) Elastica staining of a dermo-
hypodermal arteriole that shows 
subendothelial hyalinization (asterisk 
indicates hyalinized area) (left). 
Number of patients with hyalinized 
vessels (in %) (middle) and number of 
hyalinized vessels per patient (in %) 
(right). (b) Method for the calculation 
of the cellularity index (cells/100 μm2) 
(left) and comparison of study groups 
(right), (c) Quantification of arteriolar 
wall/lumen ratio (AWLR) showing the 
formula used (left), examples (middle; 
N.d.: not definable) and AWLR of the 
study groups (right). Boxplots are 
plotted with median, interquartile range 
(IQR) and 5th–95th percentiles. Outliers 
are indicated as dots. ns indicates not 
significant, *significant (p < 0.05) and 
**highly significant (p < 0.01) results, 
comparing the arteriolosclerotic 
ulcer of Martorell (ASUM) group 
with the respective control group. 
Venous: venous leg ulcers; Vasculitis: 
necrotizing leukocytoclastic vasculitis; 
PG: pyoderma gangrenosum; Control N: 
non-ulcerative skin of non-hypertensive 
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structures in the arteriolar wall, the cellularity index 
was determined. The cellularity index is defined as the 
number of nuclei per 100 μm2 of arteriolar wall surface 
(Fig. 1b). The cellularity index of arterioles in patients 
with ASUM (0.13, 0.06–0.27) was significantly lower 
than that in all control groups (Venous: 0.53, 0.28–0.69, 
p < 0.001; Vasculitis: 0.44, 0.31–0.63, p < 0.001; PG: 
0.52, 0.47–0.63, p < 0.001; Control N:0.47, 0.40–0.62, 
p < 0.001; Control H: 0.50, 0.40–0.57, p < 0.001). 
Wall-to-lumen ratio
To quantify and compare the luminal obstruction, the 
ratio between the thickness of the arteriolar wall and 
the lumen was determined according to a standardized 
protocol (23). The median arteriolar wall-to-lumen ratio 
(AWLR) in the ASUM samples was 1.74 (1.33–2.18). 
AWLRs in the control groups were 0.96 (0.72–1.39), 1.01 
(0.86–1.33), 1.1 (0.82–1.75), 1.1 (0.78–1.43), and 1.23 
(0.84–1.62) for Venous ulcers, Vasculitis, PG, Control 
N, and Control H, respectively (all p < 0.05, Fig. 1c). 
However, despite the statistical significance, a more de-
tailed analysis revealed that the quartiles of patients with 
ASUM and control groups showed a substantial overlap, 
indicating a low discriminatory power.
Calcification
Arteriolar calcification was present in 51 (76%) patients 
with ASUM. In all control groups, arteriolar calcification 
could only be seen sporadically compared with that in 
the ASUM group (all p < 0.001, Fig. 2a). 
Periarteriolitis
Periarteriolitis is characterized by immune cell infil-
trates next to the arteriolar wall. In 61 (91%) patients 
with ASUM, periarteriolitis was detected in at least one 
vessel, as well as in 10 (67%), 13 (87%), 15 (100%), 7 
(47%) and 6 (40%) patients of the Venous, Vasculitis, 
PG, Control N, and Control H groups, respectively. The 
mean percentage of affected vessels was 73% (± 31.3), 
44% (± 41.3), 82% (± 35.9), 98.7% (± 5.2), 22.1% (± 28.3) 
and 18.9% (± 31.4) in the ASUM, Venous, Vasculitis, 
PG, Control N, and Control H groups, respectively 
(Fig. 2c). To quantify the severity, periarteriolitis was 
graded from 0 (no periarteriolitis) to 4 (severe peri-
arteriolitis). The median severity scores were 1.45 
(0.79–1.85), 0.56 (0.00–2.67), 1.00 (1.00–2.00), 3.00 
(2.20–4.00), 0.00 (0.00–0.50) and 0.00 (0.00–0.25) 
for the ASUM, Venous, Vasculitis, PG, Control N, and 
Control H groups, respectively. In both assessments, 
Fig. 2. Assessment of calcification and 
periarteriolitis. (a) von Kossa-stained 
arteriolosclerotic ulcer of Martorell (ASUM) 
sample showing an arteriolar vessel with 
calcification (left) and number of patients 
with calcified vessels (in %) (right), (b) 
Periarteriolitis grading scale from 0 (no 
periarteriolitis) to 4 (severe periarteriolitis) 
(c) Number of vessels with periarteriolitis per 
patient (in %, left) and mean periarteriolitis 
grade of vessels per patient (right). Column bar 
graphs are displayed with mean and standard 
deviation. ns: not significant, *significant 
(p < 0.05) and **highly significant (p < 0.01) 
results comparing the ASUM group with the 
respective control group. Magnification: a) 
von Kossa staining: 400x. b) Periarteriolitis 
Grading: 0, 1, 2: 250x; 3, 4: 400x. Venous: 
venous leg ulcers; Vasculitis: necrotizing 
leukocytoclastic vasculitis; PG: pyoderma 
gangrenosum; Control N: non-ulcerative 
skin of non-hypertensive controls; Control H: 
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only the differences in the ASUM group compared with 
those in the PG, Control N, and Control H groups were 
statistically significant (p < 0.001, Fig. 2c). 
Convolutional neural network analysis
Convolutional neural network (CNN) analysis was per-
formed to evaluate the histomorphological distinguisha-
bility between the ASUM and control groups. Automated 
predictions of 523 test images showed a mean sensitivity 
of 0.882 (95% CI 0.834–0.931), specificity of 0.7 (95% 
CI 0.446–0.954), and an area under the ROC curve 
(AUC) of 0.889 (95% CI 0.824–0.995). Fig. 3a shows 
the application of Grad-CAM (26) to image crops, where 
image regions with the 200 highest and lowest activation 
values for ASUM were extracted to interpret probably 
useful distinctive features, as perceived by the CNN. 
Manual qualitative post-hoc analysis of the resulting 
image regions with the highest activation for ASUM 
showed hypocellular (81%), lamellar convex (19%), and 
strongly eosinophilic (3.5%) features, corresponding to 
hyalinosis and basophilic regions indicating calcifica-
tion (13.5%).
Discriminatory power and biostatistical analysis
A logistic regression model was defined using the diag-
nosis of ASUM vs controls as target variable and wall-
to-lumen ratio, calcification, hyalinosis and cellularity 
index as explanatory variables. A second model with only 
calcification and cellularity index as explanatory variables 
was calculated. Odds ratios (OR) for calcification, hya-
linosis, and cellularity were significantly different from 
1. Calcified vessels were more likely found in patients 
with ASUM (OR 42.7, 95% CI 7.4–444.0, p < 0.001). 
Similarly, patients with ASUM were more likely to have 
vessels with hyalinosis (OR 29.3, 95% CI 4.9–278.2, 
p < 0.001). Patients with ASUM showed lower cellularity 
(OR 0.003, 95% CI < 0.001–0.97, p = 0.05). The AWLR 
did not significantly differ (OR 0.98, 95% CI 0.60–2.04, 
p = 0.929). The AUC values of 0.983 (all parameters 
included) and 0.971 (only cellularity and calcification) 
suggest a good diagnostic ability of both models (Fig. 3b). 
The optimal cut-off values for cellularity based on 
the Youden index were 0.24 (if no calcification was 
observed) and 0.64 (if calcification was observed). 
Classifying individuals with lower cellularity than the 
Fig. 3. Convolutional neural 
network (CNN) analysis and 
logistic regression model. (a) 
Analysis of a convolutional neural 
network trained to distinguish 
arteriolosclerotic ulcer of Martorell 
(ASUM) from controls, based on 
vessel-centred image crops. Grad-
CAM (26) analysis for ASUM-prediction 
on an example image (upper left) 
shows the highest activation within 
the vessel wall (upper middle and 
right). Extraction of the 200 image 
areas of the highest and lowest 
ASUM-activation of all training and 
test images (lower left and middle) 
indicate more eosinophilic colour 
and hypocellularity as objective 
distinctive features. Manual review 
of highly ASUM-activated areas 
of the test images is shown on 
the right, (b) Receiver operating 
characteristic (ROC) curve of the 
logistic regression model with the 
diagnosis ASUM vs controls as the 
target variable and wall/lumen ratio, 
calcification, hyalinosis and cellularity 
as the explanatory variables (red) 
and with cellularity and calcification 
as explanatory variables (blue). (c) 
Evaluation of ASUM and controls 
using 2 criteria, cellularity index (Cel) 
< 0.24 and presence of calcification 
(Cal). Purple box indicates patients, 
who fulfil at least 1 criterion. The 
blue box indicates patients, who fulfil 
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above-mentioned thresholds will result in a sensitivity 
of 0.955 and a specificity of 0.944 for the diagnosis of 
ASUM. When “cellularity < 0.24” and “presence of cal-
cification” were applied as criteria, 97% of patients with 
ASUM and only 5.3% of the controls fulfilled at least 
one of the criteria (Fig. 3c and Fig. S11). 
The presence of hyalinosis and calcification in patients 
with ASUM did not differ significantly depending on the 
comorbidities, including DM II, chronic kidney disease, 
PAOD, and CVI. However, calcification of arterioles was 
significantly more frequent in patients taking vitamin K 
antagonists (92% vs 67%; p = 0.036; Fig. 4).
DISCUSSION
ASUM represents an important differential diagnosis of 
leg ulcers of vascular origin. However, its diagnosis is 
challenging, given the lack of clearly affirmative instru-
Fig. 4. Presence of hyalinization and calcification in 
arteriolosclerotic ulcer of Martorell (ASUM), dependent 
on comorbidities. Presence of hyalinization and calcification 
in samples of patients with ASUM is dependent on the following 
comorbidities: arterial hypertension, diabetes mellitus type II 
(Diabetes), peripheral arterial occlusive disease (PAOD), chronic 
venous disease (CVD), and intake of vitamin K inhibitors. ns: 
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ment-based diagnostic criteria. Consequently, ASUM 
poses a major risk of underdiagnosis or misdiagnosis, 
which is particularly disconcerting considering reports 
of misdiagnosis with other types of leg ulcers, potentially 
resulting in fatal complications due to immunosuppressive 
treatment (1, 7–10). Although several different histological 
findings in patients with ASUM have been reported, there 
are no generally accepted, validated histological criteria 
for ASUM available to date (6, 8, 16, 20, 21). The presence 
of “stenosing arteriolosclerosis”, composed of hyalinosis, 
muscular hypertrophy, and calcification, has been conside-
red the histological hallmark of ASUM by several authors 
(6, 13, 18, 19). Hyalinosis, which is characterized by the 
accumulation of an amorphous eosinophilic substance, 
supposedly consisting of plasma proteins, collagen, lipids, 
and basement membrane material, in the media of arterio-
lar vessels, is mostly accompanied by the loss of smooth 
muscle cells involving hardening and loss of elasticity 
of the arteriolar wall (27–29). Although it has been re-
ported by several authors (7, 13, 20, 30, 31), the term 
“hyalinosis” represents a rather unspecific term. The 
exact molecular composition of these hyaline suben-
dothelial deposits in ASUM has not been elucidated thus 
far. Howe ver, given the reports on similar histological 
changes in some non-ulcerative hypertensive patients 
(23), the specificity of these findings has been questioned 
(8, 16). 
The aim of the present study was to perform a syste-
matic multimodal microstructural comparative analysis 
of skin biopsies of a large series of patients diagnosed 
with ASUM and different ulcerative and non-ulcerative 
control groups. To achieve a maximum number of typical 
ASUM cases, the patient material from 3 independent 
European wound care centres was combined. String-
ent eligibility criteria were initially applied to exclude 
ulcers that may also harbour another, particularly ma-
crovascular, aetiological component. To investigate their 
specificity, the histological signs of arteriolosclerosis 
and -stenosis found in ASUM were compared with the 
most important clinical differential diagnoses of ASUM, 
namely venous leg ulcers, necrotizing leukocytoclastic 
vasculitis, pyoderma gangraenosum, and non-ulcerative 
non-hypertensive as well as hypertensive controls. A 
multivariable regression model with ASUM as the target 
variable and wall-to-lumen ratio, calcification, hyalino-
sis, and cellularity as explanatory variables showed that 
calcified vessels occurred significantly more often in 
patients with ASUM in addition to vessels with hyali-
nosis. While the AWLR did not significantly differ, the 
cellularity indices were significantly higher in all control 
groups. Therefore, arteriolar calcification, subendothelial 
hyalinosis, and decreased cellularity (with a cellularity 
index of < 0.24 cells/100 μm2 representing the optimum 
cut-off value based on the Youden index) revealed high 
discriminatory power for ASUM compared with that for 
ulcerative and non-ulcerative controls. 
These observations were supported by an operator-
independent CNN analysis, as the image regions with 
highest activation for ASUM showed hypocellular, 
lamellar convex, and eosinophilic regions correspon-
ding to hyalinosis, and strongly basophilic regions 
correspond ing to calcification. 
The presence of hyalinosis and calcification did not 
differ based on comorbidities, including DM II, chronic 
kidney disease, PAOD, and CVI. However, calcification 
of arterioles was significantly more frequent in patients 
taking vitamin K antagonists. This is consistent with the 
hypothesis that vitamin K deficiency promotes vascular 
calcification by decreasing the activation of matrix Gla-
protein, which is synthesized by vascular smooth muscle 
and endothelial cells and acts as a strong inhibitor of 
vascular calcification by keeping the extracellular matrix 
free of calcium deposits (32–34). 
Study limitations
This study has several limitations. One major limita-
tion is the retrospective study design. The patient data 
was collected from 3 different study centres and finally 
combined to achieve the maximum number of cases. In 
addition, differences in diagnostic work-up and histolo-
gical sample processing cannot be fully excluded. Due to 
the rather limited incidence of the disease, patients with 
ASUM were collected over a long study period of 21 
years, which brings about a heterogeneous study popu-
lation, particularly regarding therapeutic measures of 
ASUM as well as of secondary factors, such as the use of 
anticoagulants or the use of different standard antihyper-
tensive drugs, which has changed over the years. These 
differences in pharmaceutical interventions might have 
also had an impact on the disease course and histological 
findings, such as the presence of arteriolar calcification. 
Several patients had to be excluded a priori, due to 
the presence of a relevant concomitant macrovascular 
disease. However, this selection process also represents 
a potential bias with regard to the extrapolation of the 
findings to a non-selected patient population in daily 
clinical routine.
Conclusion
This study provides quantitative histomorphological 
information on arteriolar wall changes in patients with 
ASUM in comparison with that in ulcerative and/or non-
ulcerative controls. Overall, both manual and operator-
independent computational histomorphological analysis 
suggest arteriolar calcification and hyalinosis (quanti-
fied by decreased wall cellularity, particularly < 0.24 
cells/100 μm2) as the main discriminatory parameters in 
the microstructural differential diagnosis of ASUM from 
other leg ulcer entities. This may facilitate the histologi-
cal diagnosis in unclear cases in the future. However, 
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the aetiopathogenesis of the disease, involving a loss of 
cellularity in the subendothelial arteriolar wall. Future 
studies will have to further unravel the exact molecular 
composition of this acellular fibrosclerosis. This would 
allow for: (i) a more detailed understanding of the un-
derlying pathophysiological mechanisms, (ii) a potential 
molecular differentiation from the vascular acellular 
fibrosclerosis observed in other types of diseases, such as 
diabetic ulcers (10), and (iii) the development of future 
therapeutic strategies targeting these vascular deposits 
in affected patients.
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